L. Cook

发表

Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.

E. Jaffe, R. Childs, P. Vo, 2013, Clinical lymphoma, myeloma & leukemia.

Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trial

N. Geller, R. Childs, G. Calandra, 2016, Haematologica.

The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches.

P. Muranski, C. Hourigan, A. Barrett, 2014, Cytotherapy.

The Clinical and Financial Burden of Preemptive Management of CMV Disease after Allogeneic Stem Cell Transplantation – Implications for Preventative Treatment Approaches

P. Muranski, R. Childs, J. Barrett, 2014 .

Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation

R. Childs, E. McDuffee, T. Worthy, 2017, Bone Marrow Transplantation.

Differences in the Phenotype, Cytokine Gene Expression Profiles, and In Vivo Alloreactivity of T Cells Mobilized with Plerixafor Compared with G-CSF

J. P. McCoy, N. Geller, J. Joo, 2013, Journal of Immunology.

Plerixafor Compared with G-CSF Alloreactivity of T Cells Mobilized with Expression Profiles, and In Vivo Differences in the Phenotype, Cytokine Gene

J. P. McCoy, C. Dunbar, Susan Wong, 2013 .

Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor

R. Childs, J. Barrett, S. Leitman, 2015, Journal of Hematology & Oncology.

Engraftment of donor cells with germ-line integration of HHV6 mimics HHV6 reactivation following cord blood/haplo transplantation.

G. Fahle, R. Danner, R. Childs, 2014, Blood.

Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non‐mobilized donor T cells for refractory severe aplastic anaemia

N. Young, D. Stroncek, R. Childs, 2017, British journal of haematology.

Adoptive Transfer of Escalating Doses of Ex Vivo Expanded Autologous Natural Killer (NK) Cells In Patients with Advanced Malignancies Following Bortezomib Treatment to Sensitize to NK-TRAIL Cytotoxicity

K. Keyvanfar, D. Stroncek, M. Berg, 2010 .

A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo‐immunized patients

S. Adams, W. Flegel, R. Childs, 2020, British journal of haematology.

Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.

N. Geller, N. Young, P. Scheinberg, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid donor T‐cell engraftment increases the risk of chronic graft‐versus‐host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes

N. Geller, N. Young, D. Stroncek, 2013, American journal of hematology.

NK Cell KIR Ligand Mismatches Influence Engraftment Following Combined Haploidentical and Umbilical Cord Blood (UCB) Transplantation In Patients With Severe Aplastic Anemia (SAA)

D. Stroncek, R. Childs, S. Leitman, 2013 .

Reduced Incidence of Acute Graft Versus Host Disease (GVHD) and Transplant-Related Mortality (TRM) with the Addition of Short-Course Mini-Dose Methotrexate (MTX) to Cyclosporine (CSA) as GVHD Prophylaxis Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

N. Geller, H. Hedlin, R. Srinivasan, 2007 .

Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome

N. Geller, S. Adams, D. Stroncek, 2021, British journal of haematology.

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers

N. Geller, J. Tisdale, R. Childs, 2011, British journal of haematology.

Significant Alterations in T-Cell TH1 and TH2 Cytokine Gene Profiles Associated with G-CSF Mobilization Do Not Occur in T-Cells Mobilized with AMD3100.

N. Geller, R. Childs, A. Lundqvist, 2007 .

Haematopoietic stem cell transplant patients have a high initial failure rate to hepatitis B vaccination that can be overcome with subsequent vaccination series

Thomas E. Hughes, X. Tian, Tracey L Walsh-Chocolaad, 2021, British journal of haematology.

Chronic GVHD manifesting as parotitis after allogeneic hematopoietic SCT

N. Patronas, R. Childs, M. Ramanathan, 2009, Bone Marrow Transplantation.

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers

N. Geller, J. Tisdale, R. Childs, 2011, British journal of haematology.